CAR-T treatment for leukemia is an innovative process that uses your own immune cells to seek and destroy cancerous cells.
After some blood is taken from the patient, the T-cells, a type of immune cell, are removed from the sample. Using advanced genetic engineering techniques, the T-cells are modified, causing them to create chimeric antigen receptors (CARs). These CARs program the T-cells to find and destroy cancer cells when injected back into the patient.
The patient receives chemotherapy while the modified T-cells grow in our laboratory. The chemotherapy dampens the patient’s immune system, permitting the CAR T-cells to do a better job of eliminating malignant cells.
Cancer Cell
Engineered T-Cells
CAR-T therapy is limited to patients under 50 years of age because of possible side effects. Additionally, potential patients need to have undergone at least two prior leukemia treatments. The CAR-T protocol requires hospitalization of at least two weeks, but same patients may need a longer observation period.
Great success has been achieved in young patients with CAR-T treatment. The following are the rates of complete recovery with this therapy:
Of course, Sheba continues to strive to further improve these rates through continuous research and retaining the best physicians.
If you have a loved one suffering from leukemia, contact us right away. We’ll be happy to answer all your questions and help in every possible way.
For more information from one of our medical tourism consultants Fill in the form below or call us at +972-77-9966905
Established in 1948, Sheba Medical Center is now the leading medical center in the region.
